Cigna Corp (CI)
$353.99
7.52 (2.17%)
CI Stock Quote Delayed 30 Minutes
Express Scripts (ESRX) a Sell on Falling Sales Growth
Express Scripts Holdings Co (NASDAQ:ESRX) is classified as a member of the 82 company Health Care Providers & Services GICS industry group, which is part of the 783 company GICS Health Care sector. ESRX's market value is $35.2 billion which places it in the top decile in its industry group. The ranking for ESRX by Portfolio Grader places it 57 among the 82 companies in this industry group, giving it a below-average spot; in the third quartile of the sector with a ranking of 505 among the 783 companies in the sector, and number 3,369 in the nearly 5,000 company Portfolio Grader universe.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
120.39B
PE Ratio
27.83
EPS
12.72
Volume (Avg. Vol.)
1.43M
Day's Range
$346.15 - $354.49
52-Week Range
$253.95 - $365.71
Dividend & Yield
$4.92 (1.39%)
CI Stock Predictions, Articles, and Cigna Corp News
Express Scripts (ESRX) a Sell on Shrinking Quant Score
Currently, Express Scripts Holdings Co (NASDAQ:ESRX) has a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 11 months.
Anthem Inc (ANTM), CVS Health Corp (CVS) Team Up in Prescription Drugs Deal
Anthem (ANTM) and CVS Health (CVS) have announced that they are teaming up to create a new pharmacy benefits manager in 2020.
Outstanding Quant Score Makes Cigna (CI) a Strong Buy
Portfolio Grader currently ranks Cigna Corporation (NYSE:CI) a Strong Buy. The methods for investing incorporated in this analytical tool developed by Louis Navellier assesses and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking CI has had from Portfolio Grader for 2 months.
Stock of Express Scripts (ESRX) Ranked a Sell
Express Scripts Holdings Co (NASDAQ:ESRX) is ranked as a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. ESRX has maintained this ranking for 11 months.
Strong Buy Ranking for Cigna (CI) Kept
Cigna Corporation (NYSE:CI) is ranked as a Strong Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CI has maintained this ranking for the last month.
Express Scripts Holding Company (ESRX) Buys eviCore Healthcare in $3.6B Deal
Express Scripts (ESRX) has announced that it will be acquiring eviCore Healthcare for $3.6 billion in a deal that will close by 2017's end.
Stock of Express Scripts (ESRX) Ranked a Sell
Express Scripts Holdings Co (NASDAQ:ESRX) is ranked as a Sell using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. ESRX has maintained this ranking for 11 months.
Strong Buy Ranking for Cigna (CI) Kept
Cigna Corporation (NYSE:CI) is ranked as a Strong Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. CI has maintained this ranking for the last month.
Rite Aid Corporation (RAD) Stock Looks Tempting, But It’s Still Trouble
Rite Aid actually looks cheap in some ways, but as profits decline, that advantage will disappear. Don't buy this "bottom" in RAD stock.
3 Big Stock Charts for Tuesday: Akamai Technologies, Inc. (AKAM), Dollar Tree, Inc. (DLTR) and Express Scripts Holding Company (ESRX)
Shares of Akamai Technologies (AKAM), Dollar Tree (DLTR) and Express Scripts (ESRX) all jumped more than 1% yesterday, but only one of these is flashing a real buy signal.
Is This Rite Aid Corporation’s (RAD) Final Earnings Report?
Rite Aid will either merge into Walgreens, find another buyer or disappear. Those buying RAD stock today should expect a sale soon.
The Next Big Amazon.com, Inc. (AMZN) Stock Catalyst
Not that Amazon (AMZN) hasn't done just fine without it, but if AMZN stock gets back into the online prescription business, look out above.
Anthem Inc (ANTM) Asks Supreme Court to Review Blocked Merger With Cigna Corporation (CI)
Anthem (ANTM) isn't ready to give up on its merger with Cigna (CI) and it is now seeking aid from the Supreme Court on the matter.
Why AK Steel Holding Corporation (AKS), Barrick Gold Corp (USA) (ABX) and Express Scripts Holding Company (ESRX) Are 3 of Today’s Worst Stocks
Express Scripts (ESRX), AK Steel (AKS) and Barrick Gold (ABX) couldn't jump on board Tuesday's bullish train.
3 Stocks to Watch on Tuesday: Alcoa Corp (AA), Caterpillar Inc. (CAT) and Express Scripts Holding Company (ESRX)
Caterpillar (CAT) and Alcoa (AA) are making big moves thanks to Street-beating reports, but Express Scripts (ESRX) is hurtling lower.
Is Rite Aid Corporation (RAD) Stock Worth the Risk Anymore?
Rite Aid (RAD) continues to struggle as doubts grow that a Walgreens (WBA) merger won't pass. But there's still opportunity in RAD stock.
